National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 344609

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 344609
Age:13.0
Gender:Female
Location:Arizona
Vaccinated:2006-10-17
Onset:2007-02-01
Submitted:2009-04-21
Entered:2009-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Anaemia, Antinuclear antibody, Arthralgia, Back pain, C-reactive protein, Fatigue, Gait disturbance, Gingival disorder, Haematocrit decreased, Haemoglobin decreased, Headache, Hypoaesthesia, Joint effusion, Musculoskeletal pain, Nausea, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain in jaw, Polyarthritis, Rash, Red blood cell count decreased, Rheumatoid factor positive, White blood cell count increased, Red blood cell sedimentation rate increased, Juvenile arthritis, Synovial fluid analysis abnormal, Parvovirus B19 serology positive, Limb discomfort, Pigmentation disorder, Hepatitis C test negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions: Unknown. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Acute brachial neuritis, URI, sinusitis, rash L hip. Fatigue and weakness. Stiffness, joint pain/swelling and muscle weakness/tenderness of R shoulder, neck, R knee, arms. Headaches, dizziness, muscle spasms and sensitivity or pain of hands and/or feet
Diagnostic Lab Data: serum ANA protein, 04/18/07, 1/80; serum rheumatoid factor, 04/24/07, 24.7; serum C-reactive, 04/24/07, 2.7; serum cyclic citrulline, 04/18/07, positive. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. LA
CDC 'Split Type': WAES0904USA02303

Write-up:Initial and additional information has been received from a nurse practitioner concerning a 14 year old female who on 17-OCT-2006 was vaccinated with the first 0.5 ml dose of GARDASIL (lot #: 653735/0688) into the left shoulder. Concomitant therapy included ZYRTEC. In February 2007, the patient developed neck and right shoulder pain, later the patient was diagnosed with juvenile rheumatoid arthritis. The patient was seen by a rheumatologist. On 18-APR-2007, the patient''s laboratory test revealed homogeneous antinuclear antibody (ANA) pattern 1 per 80. On 24-APR-2007, the patient''s laboratory revealed rheumatoid factor 24.7 and C-reactive protein (CRP) 2.7. On 25-SEP-2007 the patient was seen by another rheumatologist. The patient also saw another physician and a homeopathic physician. On 21-APR-2008, the patient was seen by an orthopedist. On 09-APR-2009, the patient was seen by the physician in the reporter''s office. The reporter stated that while the patient was waiting to see the physician, she was seated in a cross-legged position. It was reported the patient''s mother request the patient to receive a whole body MRI. The physician was unable to examine the patient due to the patient''s pain. The whole body was not ordered by the physician. The reporter stated that she thought the patient''s mother was relating the patient''s condition to the GARDASIL. Follow-up information was received from a medical assistant in a rheumatologist''s office. The medical assistant stated that the patient was first seen the rheumatologist on 18-APR-2007. The patient''s laboratory tests revealed a positive rheumatoid factor and a positive anti-CCP (anti-cyclic citrullinated peptide) test. The patient was diagnosed with juvenile rheumatoid arthritis. The medical assistant stated that there was no mention of the patient receiving the GARDASIL vaccine in the physician''s notes. The patient was no longer a patient of the rheumatologist. Juvenile rheumatoid arthritis was considered to be disabling. Additional information has been requested.


Changed on 8/31/2010

VAERS ID: 344609 Before After
Age:13.0
Gender:Female
Location:Arizona
Vaccinated:2006-10-17
Onset:2007-02-01
Submitted:2009-04-21
Entered:2009-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Anaemia, Antinuclear antibody, Arthralgia, Back pain, C-reactive protein, Fatigue, Gait disturbance, Gingival disorder, Haematocrit decreased, Haemoglobin decreased, Headache, Hypoaesthesia, Joint effusion, Musculoskeletal pain, Nausea, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain in jaw, Polyarthritis, Rash, Red blood cell count decreased, Rheumatoid factor positive, White blood cell count increased, Red blood cell sedimentation rate increased, Juvenile arthritis, Synovial fluid analysis abnormal, Parvovirus B19 serology positive, Limb discomfort, Pigmentation disorder, Hepatitis C test negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions: Unknown. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Acute brachial neuritis, URI, sinusitis, rash L hip. Fatigue and weakness. Stiffness, joint pain/swelling and muscle weakness/tenderness of R shoulder, neck, R knee, arms. Headaches, dizziness, muscle spasms and sensitivity or pain of hands and/or feet
Diagnostic Lab Data: serum ANA protein, 04/18/07, 1/80; serum rheumatoid factor, 04/24/07, 24.7; serum C-reactive, 04/24/07, 2.7; serum cyclic citrulline, 04/18/07, positive. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. LA
CDC 'Split Type': WAES0904USA02303

Write-up:Initial and additional information has been received from a nurse practitioner concerning a 14 year old female who on 17-OCT-2006 was vaccinated with the first 0.5 ml dose of GARDASIL (lot #: 653735/0688) into the left shoulder. Concomitant therapy included ZYRTEC. In February 2007, the patient developed neck and right shoulder pain, later the patient was diagnosed with juvenile rheumatoid arthritis. The patient was seen by a rheumatologist. On 18-APR-2007, the patient''s laboratory test revealed homogeneous antinuclear antibody (ANA) pattern 1 per 80. On 24-APR-2007, the patient''s laboratory revealed rheumatoid factor 24.7 and C-reactive protein (CRP) 2.7. On 25-SEP-2007 the patient was seen by another rheumatologist. The patient also saw another physician and a homeopathic physician. On 21-APR-2008, the patient was seen by an orthopedist. On 09-APR-2009, the patient was seen by the physician in the reporter''s office. The reporter stated that while the patient was waiting to see the physician, she was seated in a cross-legged position. It was reported the patient''s mother request the patient to receive a whole body MRI. The physician was unable to examine the patient due to the patient''s pain. The whole body was not ordered by the physician. The reporter stated that she thought the patient''s mother was relating the patient''s condition to the GARDASIL. Follow-up information was received from a medical assistant in a rheumatologist''s office. The medical assistant stated that the patient was first seen the rheumatologist on 18-APR-2007. The patient''s laboratory tests revealed a positive rheumatoid factor and a positive anti-CCP (anti-cyclic citrullinated peptide) test. The patient was diagnosed with juvenile rheumatoid arthritis. The medical assistant stated that there was no mention of the patient receiving the GARDASIL vaccine in the physician''s notes. The patient was no longer a patient of the rheumatologist. Juvenile rheumatoid arthritis was considered to be disabling. Additional information has been requested.


Changed on 4/13/2011

VAERS ID: 344609 Before After
Age:13.0
Gender:Female
Location:Arizona
Vaccinated:2006-10-17
Onset:2007-02-01
Submitted:2009-04-21
Entered:2009-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Anaemia, Antinuclear antibody, Arthralgia, Back pain, C-reactive protein, Fatigue, Gait disturbance, Gingival disorder, Haematocrit decreased, Haemoglobin decreased, Headache, Hypoaesthesia, Joint effusion, Musculoskeletal pain, Nausea, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain in jaw, Polyarthritis, Rash, Red blood cell count decreased, Rheumatoid factor positive, White blood cell count increased, Red blood cell sedimentation rate increased, Juvenile arthritis, Synovial fluid analysis abnormal, Parvovirus B19 serology positive, Limb discomfort, Pigmentation disorder, Hepatitis C test negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions: Unknown. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Acute brachial neuritis, URI, sinusitis, rash L hip. Fatigue and weakness. Stiffness, joint pain/swelling and muscle weakness/tenderness of R shoulder, neck, R knee, arms. Headaches, dizziness, muscle spasms and sensitivity or pain of hands and/or feet
Diagnostic Lab Data: serum ANA protein, 04/18/07, 1/80; serum rheumatoid factor, 04/24/07, 24.7; serum C-reactive, 04/24/07, 2.7; serum cyclic citrulline, 04/18/07, positive. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. LA
CDC 'Split Type': WAES0904USA02303

Write-up:Initial and additional information has been received from a nurse practitioner concerning a 14 year old female who on 17-OCT-2006 was vaccinated with the first 0.5 ml dose of GARDASIL (lot #: 653735/0688) into the left shoulder. Concomitant therapy included ZYRTEC. In February 2007, the patient developed neck and right shoulder pain, later the patient was diagnosed with juvenile rheumatoid arthritis. The patient was seen by a rheumatologist. On 18-APR-2007, the patient''s laboratory test revealed homogeneous antinuclear antibody (ANA) pattern 1 per 80. On 24-APR-2007, the patient''s laboratory revealed rheumatoid factor 24.7 and C-reactive protein (CRP) 2.7. On 25-SEP-2007 the patient was seen by another rheumatologist. The patient also saw another physician and a homeopathic physician. On 21-APR-2008, the patient was seen by an orthopedist. On 09-APR-2009, the patient was seen by the physician in the reporter''s office. The reporter stated that while the patient was waiting to see the physician, she was seated in a cross-legged position. It was reported the patient''s mother request the patient to receive a whole body MRI. The physician was unable to examine the patient due to the patient''s pain. The whole body was not ordered by the physician. The reporter stated that she thought the patient''s mother was relating the patient''s condition to the GARDASIL. Follow-up information was received from a medical assistant in a rheumatologist''s office. The medical assistant stated that the patient was first seen the rheumatologist on 18-APR-2007. The patient''s laboratory tests revealed a positive rheumatoid factor and a positive anti-CCP (anti-cyclic citrullinated peptide) test. The patient was diagnosed with juvenile rheumatoid arthritis. The medical assistant stated that there was no mention of the patient receiving the GARDASIL vaccine in the physician''s notes. The patient was no longer a patient of the rheumatologist. Juvenile rheumatoid arthritis was considered to be disabling. Additional information has been requested.


Changed on 5/13/2011

VAERS ID: 344609 Before After
Age:13.0
Gender:Female
Location:Arizona
Vaccinated:2006-10-17
Onset:2007-02-01
Submitted:2009-04-21
Entered:2009-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Anaemia, Antinuclear antibody, Arthralgia, Back pain, C-reactive protein, Fatigue, Gait disturbance, Gingival disorder, Haematocrit decreased, Haemoglobin decreased, Headache, Hypoaesthesia, Joint effusion, Musculoskeletal pain, Nausea, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain in jaw, Polyarthritis, Rash, Red blood cell count decreased, Rheumatoid factor positive, White blood cell count increased, Red blood cell sedimentation rate increased, Juvenile arthritis, Synovial fluid analysis abnormal, Parvovirus B19 serology positive, Limb discomfort, Pigmentation disorder, Hepatitis C test negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions: Unknown. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Acute brachial neuritis, URI, sinusitis, rash L hip. Fatigue and weakness. Stiffness, joint pain/swelling and muscle weakness/tenderness of R shoulder, neck, R knee, arms. Headaches, dizziness, muscle spasms and sensitivity or pain of hands and/or feet
Diagnostic Lab Data: serum ANA protein, 04/18/07, 1/80; serum rheumatoid factor, 04/24/07, 24.7; serum C-reactive, 04/24/07, 2.7; serum cyclic citrulline, 04/18/07, positive. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. LA
CDC 'Split Type': WAES0904USA02303

Write-up:Initial and additional information has been received from a nurse practitioner concerning a 14 year old female who on 17-OCT-2006 was vaccinated with the first 0.5 ml dose of GARDASIL (lot #: 653735/0688) into the left shoulder. Concomitant therapy included ZYRTEC. In February 2007, the patient developed neck and right shoulder pain, later the patient was diagnosed with juvenile rheumatoid arthritis. The patient was seen by a rheumatologist. On 18-APR-2007, the patient''s laboratory test revealed homogeneous antinuclear antibody (ANA) pattern 1 per 80. On 24-APR-2007, the patient''s laboratory revealed rheumatoid factor 24.7 and C-reactive protein (CRP) 2.7. On 25-SEP-2007 the patient was seen by another rheumatologist. The patient also saw another physician and a homeopathic physician. On 21-APR-2008, the patient was seen by an orthopedist. On 09-APR-2009, the patient was seen by the physician in the reporter''s office. The reporter stated that while the patient was waiting to see the physician, she was seated in a cross-legged position. It was reported the patient''s mother request the patient to receive a whole body MRI. The physician was unable to examine the patient due to the patient''s pain. The whole body was not ordered by the physician. The reporter stated that she thought the patient''s mother was relating the patient''s condition to the GARDASIL. Follow-up information was received from a medical assistant in a rheumatologist''s office. The medical assistant stated that the patient was first seen the rheumatologist on 18-APR-2007. The patient''s laboratory tests revealed a positive rheumatoid factor and a positive anti-CCP (anti-cyclic citrullinated peptide) test. The patient was diagnosed with juvenile rheumatoid arthritis. The medical assistant stated that there was no mention of the patient receiving the GARDASIL vaccine in the physician''s notes. The patient was no longer a patient of the rheumatologist. Juvenile rheumatoid arthritis was considered to be disabling. Additional information has been requested.


Changed on 6/11/2011

VAERS ID: 344609 Before After
Age:13.0
Gender:Female
Location:Arizona
Vaccinated:2006-10-17
Onset:2007-02-01
Submitted:2009-04-21
Entered:2009-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Anaemia, Antinuclear antibody, Arthralgia, Back pain, C-reactive protein, Fatigue, Gait disturbance, Gingival disorder, Haematocrit decreased, Haemoglobin decreased, Headache, Hypoaesthesia, Joint effusion, Musculoskeletal pain, Nausea, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain in jaw, Polyarthritis, Rash, Red blood cell count decreased, Rheumatoid factor positive, White blood cell count increased, Red blood cell sedimentation rate increased, Juvenile arthritis, Synovial fluid analysis abnormal, Parvovirus B19 serology positive, Limb discomfort, Pigmentation disorder, Hepatitis C test negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions: Unknown. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Acute brachial neuritis, URI, sinusitis, rash L hip. Fatigue and weakness. Stiffness, joint pain/swelling and muscle weakness/tenderness of R shoulder, neck, R knee, arms. Headaches, dizziness, muscle spasms and sensitivity or pain of hands and/or feet
Diagnostic Lab Data: serum ANA protein, 04/18/07, 1/80; serum rheumatoid factor, 04/24/07, 24.7; serum C-reactive, 04/24/07, 2.7; serum cyclic citrulline, 04/18/07, positive. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. LA
CDC 'Split Type': WAES0904USA02303

Write-up:Initial and additional information has been received from a nurse practitioner concerning a 14 year old female who on 17-OCT-2006 was vaccinated with the first 0.5 ml dose of GARDASIL (lot #: 653735/0688) into the left shoulder. Concomitant therapy included ZYRTEC. In February 2007, the patient developed neck and right shoulder pain, later the patient was diagnosed with juvenile rheumatoid arthritis. The patient was seen by a rheumatologist. On 18-APR-2007, the patient''s laboratory test revealed homogeneous antinuclear antibody (ANA) pattern 1 per 80. On 24-APR-2007, the patient''s laboratory revealed rheumatoid factor 24.7 and C-reactive protein (CRP) 2.7. On 25-SEP-2007 the patient was seen by another rheumatologist. The patient also saw another physician and a homeopathic physician. On 21-APR-2008, the patient was seen by an orthopedist. On 09-APR-2009, the patient was seen by the physician in the reporter''s office. The reporter stated that while the patient was waiting to see the physician, she was seated in a cross-legged position. It was reported the patient''s mother request the patient to receive a whole body MRI. The physician was unable to examine the patient due to the patient''s pain. The whole body was not ordered by the physician. The reporter stated that she thought the patient''s mother was relating the patient''s condition to the GARDASIL. Follow-up information was received from a medical assistant in a rheumatologist''s office. The medical assistant stated that the patient was first seen the rheumatologist on 18-APR-2007. The patient''s laboratory tests revealed a positive rheumatoid factor and a positive anti-CCP (anti-cyclic citrullinated peptide) test. The patient was diagnosed with juvenile rheumatoid arthritis. The medical assistant stated that there was no mention of the patient receiving the GARDASIL vaccine in the physician''s notes. The patient was no longer a patient of the rheumatologist. Juvenile rheumatoid arthritis was considered to be disabling. Additional information has been requested.


Changed on 4/14/2017

VAERS ID: 344609 Before After
Age:13.0
Gender:Female
Location:Arizona
Vaccinated:2006-10-17
Onset:2007-02-01
Submitted:2009-04-21
Entered:2009-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0688F / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Anaemia, Antinuclear antibody, Arthralgia, Back pain, C-reactive protein, Fatigue, Gait disturbance, Gingival disorder, Haematocrit decreased, Haemoglobin decreased, Headache, Hypoaesthesia, Joint effusion, Musculoskeletal pain, Nausea, Neck pain, Nuclear magnetic resonance imaging abnormal, Pain in jaw, Polyarthritis, Rash, Red blood cell count decreased, Rheumatoid factor positive, White blood cell count increased, Red blood cell sedimentation rate increased, Juvenile arthritis, Synovial fluid analysis abnormal, Parvovirus B19 serology positive, Limb discomfort, Pigmentation disorder, Hepatitis C test negative, Anti-cyclic citrullinated peptide antibody positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZYRTEC
Current Illness:
Preexisting Conditions: Unknown. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Acute brachial neuritis, URI, sinusitis, rash L hip. Fatigue and weakness. Stiffness, joint pain/swelling and muscle weakness/tenderness of R shoulder, neck, R knee, arms. Headaches, dizziness, muscle spasms and sensitivity or pain of hands and/or feet
Diagnostic Lab Data: serum ANA protein, 04/18/07, 1/80; serum rheumatoid factor, 04/24/07, 24.7; serum C-reactive, 04/24/07, 2.7; serum cyclic citrulline, 04/18/07, positive. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. LA LABS and DIAGNOSTICS: Parvovirus IgG 6.6 (H). ESR 44. CRP 2.7. Proteinuria. PPD (-). X-Ray hands/feet - unremarkable. MRI Shoulder - brachial neuritis. MRI Cervical spine - Normal. CBC - WBC 12.9 K/UL (H) RBC M/UL 3.57 (L) HGB 11.4 g/dL (L) HCT 32.4% (L). SED Rate 44.00 (H). SYN CELL CT 500.00 (H). Anti CCP 48.20 (H) RF 24.70 (H). HCV (-).
CDC 'Split Type': WAES0904USA02303

Write-up:Initial and additional information has been received from a nurse practitioner concerning a 14 year old female who on 17-OCT-2006 was vaccinated with the first 0.5 ml dose of GARDASIL (lot #: 653735/0688) into the left shoulder. Concomitant therapy included ZYRTEC. In February 2007, the patient developed neck and right shoulder pain, later the patient was diagnosed with juvenile rheumatoid arthritis. The patient was seen by a rheumatologist. On 18-APR-2007, the patient''s laboratory test revealed homogeneous antinuclear antibody (ANA) pattern 1 per 80. On 24-APR-2007, the patient''s laboratory revealed rheumatoid factor 24.7 and C-reactive protein (CRP) 2.7. On 25-SEP-2007 the patient was seen by another rheumatologist. The patient also saw another physician and a homeopathic physician. On 21-APR-2008, the patient was seen by an orthopedist. On 09-APR-2009, the patient was seen by the physician in the reporter''s office. The reporter stated that while the patient was waiting to see the physician, she was seated in a cross-legged position. It was reported the patient''s mother request the patient to receive a whole body MRI. The physician was unable to examine the patient due to the patient''s pain. The whole body was not ordered by the physician. The reporter stated that she thought the patient''s mother was relating the patient''s condition to the GARDASIL. Follow-up information was received from a medical assistant in a rheumatologist''s office. The medical assistant stated that the patient was first seen the rheumatologist on 18-APR-2007. The patient''s laboratory tests revealed a positive rheumatoid factor and a positive anti-CCP (anti-cyclic citrullinated peptide) test. The patient was diagnosed with juvenile rheumatoid arthritis. The medical assistant stated that there was no mention of the patient receiving the GARDASIL vaccine in the physician''s notes. The patient was no longer a patient of the rheumatologist. Juvenile rheumatoid arthritis was considered to be disabling. Additional information has been requested. 6/19/09 Rheumatology consultant medical records received DOS 4/18/07 to 8/14/07. Assessment: Inflammatory arthritis, rheumatoid arthritis, anemia. Patient presents with neck and right shoulder pain. Numbness of R hand. ''Tightness'', pain, erythema, effusion of R knee. Loss of color left hip. Limping. Back, hip, hand and wrist aches. Sore legs and ankles. Rash on legs, knees. Tired, nauseated, headaches. Jaw pain and swelling. Wrist nodules. Soreness of gums.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=344609&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166